We are excited to launch our new fund in Japan, which reflects our track record and the increasing vibrancy of the country’s venture scene. The ¥25bn fund will continue the work of our Japan team, which partners with ambitious founders across four areas: Technology, FinTech, Healthcare and Emerging Technologies.

Since the launch of our first ¥22bn Japan fund in 2015, we have invested in 21 companies. Our team has a reputation for helping Japanese businesses expand their footprint beyond domestic markets, using the powerful reach and resources of our global ecosystem. Our team in Japan is tightly integrated with the family of Eight Roads funds and sister fund F-Prime. This second Japan fund follows the launch of a dedicated China healthcare fund in September. Further fund launches will follow in the next six months as ontinues to grow. 

The team in Japan invest primarily at the growth stage but will invest earlier if the company is truly unique or will benefit from our patient capital approach, for example in therapeutics. We provide operational help and direction to our portfolio through our 12-strong team and also with our network of venture partners.

Globally we are now invested in over 200 portfolio companies with a team of 70 investment professionals.